SUBSCRIBE
SUBSCRIBE

Horizon Therapeutics

NEWS
Horizon Therapeutics was acquired by Amgen in 2023.
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Horizon Pharma Craters as Rare Neuromuscular Drug Flunks Late-Stage Study
December 8, 2016
 · 
2 min read
San Diego's Halozyme Lands Monster R&D Deals Worth $2 Billion+ From Bristol-Myers Squibb and Roche
Deals
Another One Bites the Dust... Horizon Pharma Takes Out Bay Area’s Raptor in $800 Million Deal
September 12, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
3 Battered Biopharma Stocks Battling to Recover
July 22, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
Orphan Drug Company Horizon Pharma Projects $1 Billion+ Sales for 2016, to Double Jobs by 2020
February 9, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Horizon Pharma Lashes Out at Express Scripts After Benefits Manager Severs Ties
November 12, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Horizon Pharma Fires Back at the New York Times Report on Prescriptions Made Easy Practice
October 22, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
Amidst Hostile Takeover Attempt of Depomed, Horizon Pharma Triples Size of U.S. Headquarters
October 5, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Horizon Pharma Files Lawsuit, Seeks Change of Depomed’s Board of Directors in Takeover Attempt
August 4, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Horizon Pharma Goes Hostile With $3 Billion Bid for Depomed
July 7, 2015
 · 
2 min read
Load More

AWARDS
  • 2022 Best Places to Work
IN THE PRESS
Press Releases
FDA GRANTS FULL APPROVAL TO AMGEN’S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
November 20, 2025
 · 
25 min read
Health Canada Approves UPLIZNA (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD)
January 16, 2024
 · 
7 min read
Deals
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC
October 6, 2023
 · 
14 min read
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
October 2, 2023
 · 
7 min read
New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes
September 29, 2023
 · 
9 min read
Business
Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry
September 26, 2023
 · 
2 min read
Business
Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List
September 19, 2023
 · 
3 min read
Business
Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
September 13, 2023
 · 
7 min read
Job Trends
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
September 1, 2023
 · 
14 min read
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
August 23, 2023
 · 
4 min read
Load More